Clinical Trial Update: OCT Agreement and Crossed Precision Study

View source ↗

Summary

The document reports a completed OCT-related clinical trial update from Nidek Co. LTD regarding an OCT agreement and a crossed precision study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Diseases
• Glaucoma
• Retinal Diseases

Snippet

Sponsor: Nidek Co. LTD. | Conditions: Glaucoma, Retinal Disease | Status: COMPLETED